UNSPSC 51281506: Aminosalicylic acid

This classification denotes an antitubercular agent with the molecular formula C7H7NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B2658E0N2, chemically known as 6018-19-5 (monosodium, dihydrate) but generally known as aminosalicylic acid, which bears US NIH Compound Identifier 4649. European Medicines Agency schedules Aminosalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12862MIG.

World Health Organization schedules aminosalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, AMINOSALICYLIC ACID remains the US FDA Preferred Term for this commodity. Aminosalicylic acid bears US NLM identifiers UMLS ID C0030125 and NCI Concept Code C47394. SMILES: Oc1c(ccc(N)c1)C(=O)O.

UNSPSC 51281506 Aminosalicylic acid is a Commodity code that in recent state and local activity covers the supply of pharmaceutical products through piggyback contracts and competitive bidding processes. The scope of work reflects state and local health departments and county health authorities purchasing specific pharmaceutical inventory — antibiotics, overdose-reversal medications, and related medical supplies — through established procurement vehicles including cooperative purchasing consortiums and fixed-price supply agreements with recurring delivery schedules. Issuing bodies under this code include state departments of public health and county health authorities; the Illinois Department of Public Health and Seminole County, Florida appear as recent buyers.

Recent opportunities show minimal activity aligned directly to the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid Number 26-482DPH-PREPD-B-53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, an Invitation for Bid with a 12-month initial term and two one-year renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries and a two-year initial term plus one-year renewal option. These recent solicitations suggest the code captures a narrow slice of state and local pharmaceutical procurement activity, with issuing bodies concentrated in Florida and Illinois and work structured through annual or multi-year supply contracts requiring vendor compliance with federal regulations when FEMA funding applies.